Table 3 NCI EDRN validation cohort demographics (N = 828)
From: Validation of a novel model for the early detection of hepatocellular carcinoma
BCLC (Cirrhosis with HCC; n = 416) | Controls (cirrhosis only) (n = 412) | |||||
|---|---|---|---|---|---|---|
0 (n = 10) | A (n = 223) | B (n = 81) | C (n = 91) | D (n = 11) | ||
Age (years); mean (SD) | 59.3 (9.1) | 60.9 (10.4) | 62.1 (9.5) | 58.8 (9.7) | 63.2 (9.3) | 54.9 (8.7) |
Age range (years) | 45–77 | 37–86 | 36–82 | 26–80 | 49–75 | 25–82 |
Sex (male:female) | 60:40 | 74:26 | 91:9 | 86:14 | 73:27 | 70:30 |
Ethnicity (%) | ||||||
Caucasian | 40 | 54 | 68 | 77 | 73 | 79 |
African-American | 50 | 11 | 2 | 9 | 9 | 4 |
Asian | 0 | 23 | 24 | 9 | 9 | 7 |
American Indian or Alaska native | 0 | 9 | 2 | 3 | 0 | 8 |
Unknown/refused | 10 | 3 | 4 | 2 | 9 | 2 |
Etiology (%) | ||||||
Alcoholic | 0 | 10.8 | 14.8 | 8.8 | 0 | 11.6 |
HBV | 0 | 20.6 | 13.6 | 9. 9 | 0 | 5.6 |
HCV | 80 | 50.7 | 54.3 | 50.6 | 63.6 | 58.2 |
Others | 20 | 17.9 | 17.3 | 30.8 | 36.4 | 24.5 |